Cathepsin B, Human Liver

size
price
qty
25 ug
$155.00
Contact Us for bulk pricing.

PRODUCT NUMBER:

16-12-030102

MW: 27,500
Extinction Coefficient: 2.0

Frozen in 50 mM Na Acetate, pH 5.0, with 1 mM EDTA

Storage: -70°C or lower

Buy Purified Native Human Cathepsin B (CatB), Human Liver.
Bulk Qty Available.

Cathepsin B, a cysteine proteinase, is located in lysosomes and is involved in tissue degradation and restructuring. Specifically, cathepsin B is believed to be involved in the intracellular digestion of extracellular proteins taken up by endocytosis.

Ref: Rich D.H., Brown M.A. and Barrett A.J. 1986 Biochem J, 235, 731-734.

Activity: Greater than 200 units per mg protein. One unit is defined as the amount of enzyme that hydrolyzes one umole of Z-Arg-Arg-beta-naphthylamide per minute at 40oC, using 100 mM Na/K phosphate, pH 6.0, with 1.33 mM EDTA and 2 mM DTT as the activation buffer.

Purity: >=95% by SDS-PAGE

Prepared from tissue shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests.

Athens Research & Technology products are laboratory reagents and are not to be administered to humans or used for any drug purpose. For research or further manufacturing use only.

Product Citation:
Armstrong, Andrea, Niklas Mattsson, Hanna Appelqvist, Camilla Janefjord, Linnea Sandin, Lotta Agholme, Bob Olsson et al. "Lysosomal Network Proteins as Potential Novel CSF Biomarkers for Alzheimer’s Disease."Neuromolecular medicine 16, no. 1 (2014): 150-160.
Watson, Andre, Cara Yocum, Vaibhav Pandit, and Shiva P. Kotha. "Optimizing Polymeric Nanoparticle Core Designs for Gene Delivery." In Bioengineering Conference (NEBEC), 2013 39th Annual Northeast, pp. 1-2. IEEE, 2013.
Toneff, Thomas, Lydiane Funkelstein, Charles Mosier, Armen Abagyan, Michael Ziegler, and Vivian Hook. "Beta-Amyloid Peptides Undergo Regulated Co-Secretion with Neuropeptide and Catecholamine Neurotransmitters."Peptides (2013).
Elie, Benelita Tina, Vasilena Gocheva, Tanaya Shree, Stacie A. Dalrymple, Leslie J. Holsinger, and Johanna A. Joyce. "Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model." Biochimie 92, no. 11 (2010): 1618-1624.